Further analysis of the relationship between TOR1B expression and OS for the four breast cancer subtypes revealed that high TOR1B expression is a risk factor affecting the OS of patients with Basal-like (HR=3.22, P < 0.05) and Luminal A (HR=2.19, P < 0.05) subtypes. This evidence concerns the gene TOR1B and breast carcinoma.